ArticleMolecular biology reports2026
The AGT M235T variant and renin-angiotensin-aldosterone system parameters in a predominantly hypertensive elderly black South African cohort: a hypothesis-generating descriptive case series.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension (HTN) is a key cardiovascular risk factor, with its pathogenesis remaining incompletely understood. Blood pressure (BP) regulation involves the Renin-Angiotensin-Aldosterone System (RAAS), including the Angiotensin-converting enzyme (ACE), Angiotensin I (Ang I) and Angiotensin II (Ang II). The rs699 variant (M235T) may influence BP via the RAAS.
aimThis study aimed to evaluate the relationships between the rs699 genotypes, RAAS parameters, BP, Body mass index (BMI) and gender in a black elderly population.
methodsData were collected from 48 participants aged ≥60 years, using World Health Organization (WHO) obesity guidelines and South African Hypertension Society (SAHS) 2019 standards for HTN categories. Statistical analysis was performed using IBM SPSS version 27 and Python 3.14.
resultsMost participants possessed the rs699 variant (GG: 93.8%, AG: 4.2%). ACE levels were low in 64.6%, while Ang II was elevated in the same percentage. The majority were classified as hypertensive and obese. No significant associations were found between the rs699 variant and ACE, Ang I, Ang II, HTN, BMI or gender, though BMI showed sex-related differences in females.
conclusionOur findings suggest no significant association of the rs699 variant on RAAS or cardiometabolic parameters within the study population, warranting cautious interpretation. These findings require validation in larger and more diverse populations, as meaningful statistical inferences cannot be drawn from the current data.
Indexed as
Identifiers
42909728What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.